Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/14/2010US20100261727 2-arylbenzothiophene derivatives or pharceutically acceptable salts thereof, preparation method thereof, and pharceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as active ingredient
10/14/2010US20100261726 Treatment of aml
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261723 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
10/14/2010US20100261722 Hiv inhibiting 5, 6-substituted pyrimidines
10/14/2010US20100261721 Novel Sulphonylpyrroles
10/14/2010US20100261720 Heterocyclic compound and pharmaceutical composition thereof
10/14/2010US20100261719 Chemical compounds
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261716 Indazole-carboxamide compounds as 5-ht4 receptor agonists
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261714 Inhibitors of hiv replication
10/14/2010US20100261713 Pharmaceutical formulation containing irritant
10/14/2010US20100261712 Hematopoietic neoplasm chemotherapy
10/14/2010US20100261711 Selective anticonvulsant agents and their uses
10/14/2010US20100261710 HDAC Inhibitors
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261707 Thiadiazole derivatives for the treatment of neurodegenerative diseases
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261705 Carbostyril compound
10/14/2010US20100261704 Therapeutic agents 928
10/14/2010US20100261703 Salt and crystalline forms thereof of a drug
10/14/2010US20100261702 Thiophene derivatives as agonists of s1p1/edg1
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100261700 Beta-lactamase inhibitors
10/14/2010US20100261699 N-pyrazole-2-pyridine carboxamide derivative
10/14/2010US20100261698 Organic compounds
10/14/2010US20100261697 2-(heterocyclylbenzyl)pyridazinone derivatives
10/14/2010US20100261696 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/14/2010US20100261695 Treatment of onychomycosis and related compositions
10/14/2010US20100261693 Method for treating cushing's syndrome
10/14/2010US20100261692 Method of manufacture of compressed pharmaceutical formulation containing tibolone
10/14/2010US20100261691 Amorphous form of an anti-inflammatory compound
10/14/2010US20100261690 Novel combinations
10/14/2010US20100261689 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
10/14/2010US20100261688 Stabilization of oily suspensions comprising hydrophobic silicas
10/14/2010US20100261687 Substituted piperidines as ccr3 antagonists
10/14/2010US20100261686 Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction
10/14/2010US20100261685 Personal care composition
10/14/2010US20100261684 Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction
10/14/2010US20100261683 Selective Inhibitors for Cyclin-Dependent Kinases
10/14/2010US20100261682 Method and Means for the Treatment of Cachexia
10/14/2010US20100261681 Alpha-chloro and alpha-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof
10/14/2010US20100261679 CSF-1R, Inhibitors, Compositions, and Methods of Use
10/14/2010US20100261678 Phosphonic acid derivates ad their use as p2y12 receptor antagonists
10/14/2010US20100261677 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
10/14/2010US20100261676 Use of an Endogenous Ligand for Peroxisome Proliferator Activated Receptor Alpha to Treat Liver Disorders
10/14/2010US20100261674 Therapeutic applications of fatty acid amide hydrolase inhibitors
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261671 Inulin products with improved nutritional properties
10/14/2010US20100261670 Complexes of phosphate derivatives
10/14/2010US20100261669 Unit dosage for brain health
10/14/2010US20100261668 Inhibitors of s-adenosyl-l-methionine decarboxylase
10/14/2010US20100261667 3-ß-D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF
10/14/2010US20100261666 Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
10/14/2010US20100261665 Kinase inhibitor compounds
10/14/2010US20100261664 Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
10/14/2010US20100261663 Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof
10/14/2010US20100261662 Utilization of mural thrombus for local drug delivery into vascular tissue
10/14/2010US20100261661 Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
10/14/2010US20100261657 Use of a Granulin or a Granulin-Like Compound in the Therapy or Prophylaxis of Chronic Pains
10/14/2010US20100261656 Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100261646 Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
10/14/2010US20100261645 (carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament
10/14/2010US20100261644 (cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament
10/14/2010US20100261643 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260874 Herbal compositions and methods for treating hepatic disorders
10/14/2010US20100260868 Method of treatment using checkpoint kinase 1 inhibitors
10/14/2010US20100260864 Treatment or prevention of cancer and precancerous disorders
10/14/2010US20100260863 Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same
10/14/2010US20100260860 Methods for Treating Vasomotor Symptoms in Castrated Prostatic Cancer Patients with Low Dose Cyproterone Acetate
10/14/2010US20100260859 Controlled-release clozapine compositions
10/14/2010US20100260858 Drug delivery composition
10/14/2010US20100260856 Core particle for pharmaceutical preparation
10/14/2010US20100260855 Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
10/14/2010US20100260851 Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
10/14/2010US20100260850 Controlled Release Devices and Methods for Delivery of Nucleic Acids
10/14/2010US20100260846 Particles for delivery of nucleic acids and related devices and methods
10/14/2010US20100260844 Oral pharmaceutical dosage forms
10/14/2010US20100260842 Pseudoephedrine pharmaceutical formulations
10/14/2010US20100260841 Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
10/14/2010US20100260840 Orodispersible pharmaceutical composition of agomelatine
10/14/2010US20100260839 Aqueous film coating solution, film coated granule and tablet using the same
10/14/2010US20100260838 Method and composition for administering an nmda receptor antagonist to a subject
10/14/2010US20100260837 Bioavailable Capsule Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide Compound
10/14/2010US20100260836 Kits and methods for nutrition supplementation
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260834 Abuse-deterrent drug formulations
10/14/2010US20100260833 Abuse-proofed dosage form
10/14/2010US20100260832 Combination therapy for ovarian cancer
10/14/2010US20100260831 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010US20100260830 Liposomal Formulations of Tocopheryl Amides
1 ... 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 ... 7860